Scripps Research Institute scientists say that they have taken a step closer to understanding the cause of Friedreich’s ataxia, a debilitating neurological condition that affects tens of thousands of people worldwide, and so far has no cure. Researchers already know that the disease arises from the silencing of the gene FXN, due to an abnormally [...]

Novartis says that the US Food and Drug Administration (FDA) has approved Afinitor (everolimus) tablets for patients with subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated with tuberous sclerosis (TS), who require therapeutic intervention but are not candidates for curative surgical resection. This accelerated approval of Afinitor is based on an open-label, single-arm, [...]

Novartis says that the latest Phase III data indicates that Menveo (Meningococcal Group A, C, W135 and Y conjugate vaccine) demonstrates robust immunogenicity in infants potentially offering protection against four major serogroups of meningococcal disease. The data was presented during an oral presentation at the 48th annual meeting of the Infectious Disease Society of America [...]